Lung Diseases

Learn about the symptoms, causes, management and available treatments of rare lung disorders. Perspectives on the latest clinically relevant research, guideline updates, and new drug approvals.
Mar 25, 2025| Posted in: Autoimmune / Autoinflammatory Disorders, Diagnosis, Lung Diseases, Regulations

New Diagnostic Test for Autoimmune Pulmonary Alveolar Proteinosis

Savara Therapeutics has announced a new diagnostic test…
Oct 4, 2024| Posted in: Autoimmune / Autoinflammatory Disorders, Lung Diseases

Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare…

FcRn and Myasthenia Gravis: Pathophysiology

Richard J. Nowak, MD, MS, explains the role of neonatal fragment crystallizable receptor (FcRn) in myasthenia gravis (MG).

Hematologic Malignancies and Clinical Trial Participation: A Shared Decision-Making Approach

This 30-minute, CME-accredited program, hosted by John Kuruvilla, MD, explores best practices for discussing possible clinical trial participation with patients who have hematologic malignancies.

PAH Clinical Research Highlights: CHEST 2024

PAH is a rare, progressive disorder characterized by high blood pressure in the pulmonary arteries. Symptoms of PAH include shortness of breath (dyspnea) especially during exercise, chest pain, and fainting episodes.

FcRn and Myasthenia Gravis

This half-hour CME-accredited program, hosted by Richard J. Nowak, MD, MS, explains the role of neonatal fragment crystallizable receptor (FcRn) in myasthenia gravis (MG) and how treatments that target FcRn are being used to manage patients with MG.

Optimizing the Efficacy and Safety of Therapy for Fabry Disease

Fabry disease is an inherited disorder that results from the buildup of a particular type of fat in the body’s cells, called globotriaosylceramide or GL-3. The disorder affects many parts of the body.

Understanding the Global Differences in Lysosomal Disorders for Patient Care

Lysosomal storage diseases are a group of approximately 50 rare inherited metabolic diseases that are characterized by an abnormal build-up of various toxic materials in the body’s cells as a result of enzyme deficiencies.

Lung Diseases

Topics

Recent Videos

Social Wall

Long-Term Safety of Trofinetide for Rett Syndrome in Younger Children (2-4 years)

Improving Health Equity in Hereditary Angioedema (HAE): A Panel Discussion (Full Program)

Real World Treatment Data for Granulomatosis with Polyangiitis and Microscopic Polyangiitis